Restricted Stock Unit Agreement FOR NON-U.S. PARTICIPANTSRestricted Stock Unit Agreement • March 4th, 2021 • Schrodinger, Inc. • Pharmaceutical preparations • Delaware
This grant of RSUs satisfies in full all commitments that the Company has to the Participant with respect to the issuance of stock, stock options or other equity securities.
Schrödinger, Inc. NONSTATUTORY STOCK OPTION AGREEMENT Granted under 2021 Inducement Equity Incentive PlanNonstatutory Stock Option Agreement • March 4th, 2021 • Schrodinger, Inc. • Pharmaceutical preparations
This option satisfies in full all commitments that the Company has to the Participant with respect to the issuance of stock, stock options or other equity securities.
COLLABORATION AND LICENSE AGREEMENTCollaboration and License Agreement • March 4th, 2021 • Schrodinger, Inc. • Pharmaceutical preparations • New York
This Collaboration and License Agreement (this “Agreement”) is made and entered into as of November 22, 2020 (the “Effective Date”) by and between Schrödinger, Inc., a corporation organized under the laws of the State of Delaware, having its principal place of business at 120 West 45th Street, 17th Floor, New York, New York, 10036 (“Schrödinger”), and Bristol-Myers Squibb Company, a Delaware corporation headquartered at 430 East 29th Street, 14th Floor, New York, New York, USA 10016 (“BMS”). Schrödinger and BMS are sometimes referred to herein individually as a “Party” and collectively as the “Parties”.
Schrödinger, Inc. RESTRICTED STOCK UNIT AGREEMENT Granted under 2021 Inducement Equity Incentive PlanRestricted Stock Unit Agreement • March 4th, 2021 • Schrodinger, Inc. • Pharmaceutical preparations
This grant of RSUs satisfies in full all commitments that the Company has to the Participant with respect to the issuance of stock, stock options or other equity securities.
